272 related articles for article (PubMed ID: 6630299)
21. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
22. Anti-Friend virus antibody-induced resistance of Friend virus-infected spleen cells to lysis mediated by anti-H-2 antisera.
Bubbers JE; Lilly F
Cancer Res; 1978 Sep; 38(9):2722-8. PubMed ID: 679177
[No Abstract] [Full Text] [Related]
23. Effect of serum from mice with dormant Friend leukemia viral infections on synthesis and modulation of erythroleukemia cell surface gp70.
Callahan RM; Marx PA; Marum WG; Wheelock EF
J Immunol; 1980 Aug; 125(2):616-22. PubMed ID: 6930443
[TBL] [Abstract][Full Text] [Related]
24. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells.
DiCicco LM; Truitt GA; Wheelock EF
Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990
[TBL] [Abstract][Full Text] [Related]
25. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development.
Miyazawa M; Fujisawa R; Ishihara C; Takei YA; Shimizu T; Uenishi H; Yamagishi H; Kuribayashi K
J Immunol; 1995 Jul; 155(2):748-58. PubMed ID: 7541823
[TBL] [Abstract][Full Text] [Related]
26. Immunoprotective determinants in friend murine leukemia virus envelope protein.
Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
[TBL] [Abstract][Full Text] [Related]
27. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
Stackpole CW; Demsey A
Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
[TBL] [Abstract][Full Text] [Related]
28. Redistribution and modulation of Gross murine leukemia virus antigens induced by specific antibodies.
Ioachim HL; Sabbath M
J Natl Cancer Inst; 1979 Jan; 62(1):169-80. PubMed ID: 281570
[TBL] [Abstract][Full Text] [Related]
29. Induction of protective immunity to Friend murine leukemia virus in genetic nonresponders to virus envelope protein.
Ishihara C; Miyazawa M; Nishio J; Chesebro B
J Immunol; 1991 Jun; 146(11):3958-63. PubMed ID: 2033265
[TBL] [Abstract][Full Text] [Related]
30. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia.
Kitagawa M; Matsubara O; Kasuga T
Cancer Res; 1986 Jun; 46(6):3034-9. PubMed ID: 2870802
[TBL] [Abstract][Full Text] [Related]
31. Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain.
Kitagawa M; Aizawa S; Kamisaku H; Sado T; Ikeda H; Hirokawa K
Exp Hematol; 1996 Oct; 24(12):1423-31. PubMed ID: 8913289
[TBL] [Abstract][Full Text] [Related]
32. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
[TBL] [Abstract][Full Text] [Related]
33. Reciprocal interference between milk-transmitted mammary tumor virus and Friend leukemia viruses in mice: possible role of the interferon system.
Basolo F; Toniolo A; Bistocchi M; Fontanini G; Squartini F
Cancer Res; 1986 Aug; 46(8):4064-70. PubMed ID: 2425940
[TBL] [Abstract][Full Text] [Related]
34. Interspecies determinants of Friend leukemia virus antigens involved in cytolysis of virus-pfoducing cells.
Collins JJ; Bolio LD; Denny TP; Bolognesi DP
J Virol; 1977 Jan; 21(1):113-8. PubMed ID: 64623
[TBL] [Abstract][Full Text] [Related]
35. Growth properties, differentiation capacity and oncogene expression in metastatic and nonmetastatic Friend leukemia cell variants.
Sala A; Benedetto A; Elia G; Pulciani S; Ciotta C; Parlanti E; Santodonato L; Belardelli F
Invasion Metastasis; 1991; 11(4):192-203. PubMed ID: 1765432
[TBL] [Abstract][Full Text] [Related]
36. Immunofluorescence study of thymuses of mice given Friend leukemia virus: conventional vs monoclonal antibodies.
Ranucci A; Accinni L; Del Gobbo V; Titti F; Fiorucci G; Manzari V; Premrov MG; Tonietti G
Microbiologica; 1985 Jan; 8(1):1-9. PubMed ID: 3883101
[TBL] [Abstract][Full Text] [Related]
37. Absence of macrophage involvement in the passive serum therapy of Friend leukemia virus-induced disease.
Collins JJ; Snyderman R
Cancer Res; 1980 Mar; 40(3):557-62. PubMed ID: 6258783
[TBL] [Abstract][Full Text] [Related]
38. In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.
Iglehart JD; Ward EC; Thiel K; Huper G; Geier SS; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):107-15. PubMed ID: 6942181
[TBL] [Abstract][Full Text] [Related]
39. Suppression of Friend leukemia cell-induced tumours by cellular preparations of Candida albicans.
Cassone A; Scaringi L; Pesce CD; Titti F; Bistoni F; Marconi P; Rossi GB
Microbiologica; 1983 Jul; 6(3):207-20. PubMed ID: 6355774
[TBL] [Abstract][Full Text] [Related]
40. Cellular and serum involvement in protection against Friend leukemia virus.
Schuller GB; Morahan PS
Cancer Res; 1977 Nov; 37(11):4064-9. PubMed ID: 908040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
